1. National

Prostate cancer drug approved

The National Institute for Health and Clinical Excellence (Nice) has revised its recommendations on a drug to treat advanced prostate cancer.

The institute now says Abirateron, marketed as Zytiga, should be given to patients on the NHS.

View all 4 updates ›

Charity: Prostate cancer drug allows improved life quality at difficult time

Owen Sharp, of the Prostate Cancer Charity, says the Abirateron drug allows prostate cancer patients to have "a full and active life."

The drug "improves the level of pain the men have...and means they can be full participants with their family and everyday activity at a time when they are coming towards the end of their life," he says.

More top news